Part scientist, part strategist, full-time translator between what biology knows & what tech can do.
Jan 30, 2026
•
7 min read
The advantage is shifting from adding more steps to proving what can be removed by measuring predictivity and using AI inside clear guardrails.
Jan 29, 2026
9 min read
A Predictivity Ledger that makes evidence auditable, so you can remove steps and use AI without gambling with patient risk
Dec 31, 2025
6 min read
As tools accelerate, the differentiator is how we connect mechanistic understanding, real-world feedback, and warranted decisions that hold up under pressure
A 2026 operating rule for biology, AI, and the humans who have to sign their names to both
Nov 23, 2025
How we define “return” is shifting, from quarterly engagement and platform metrics to durable human outcomes and institutional learning
13 min read
Rewriting ROI Around Patients, Not Dashboards
Oct 26, 2025
5 min read
The value of translational science is shifting, from what we prove after the fact to what we can predict before it happens
Closing the Loop Between Attrition and Action
Sep 21, 2025
Where patients meet platforms—and the hype meets reality.
Sep 20, 2025
11 min read
Closing the Loop Between Preclinical Tools and Clinical Truths
Aug 29, 2025
Ruminations & Ramblings is a new series on the future of drug development—where scientists, executives, and investors meet at the messy middle to ask harder questions and chase fewer myths.
